Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Miho Oyasu"'
Autor:
Maya Kotturi, Mélanie Desbois, Angus Sinclair, Thierry Giffon, Dean Ng, Poonam Yakkundi, Marigold Manlusoc, Rodnie Rosete, Avneesh Saini, Bruce Keyt, Daniel Machado, Miho Oyasu, Susan Calhoun, Tasnim Kothambawala, Beatrice Wang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/7407df17c8fd4aeeb4c9fb58b7d3aba4
Autor:
Seema Singh, Rakesh Verma, Anamika Pradeep, Karen Leu, R Bruce Mortensen, Peter R Young, Miho Oyasu, Peter J Schatz, Jennifer M Green, Don M Wojchowski
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e29064 (2012)
Erythropoietin (EPO) and its cell surface receptor (EPOR) are essential for erythropoiesis; can modulate non-erythroid target tissues; and have been reported to affect the progression of certain cancers. Basic studies of EPOR expression and trafficki
Externí odkaz:
https://doaj.org/article/c61c54cb28174fa9afe7512a24610dec
Autor:
Pina M. Cardarelli, Julien Sage, Kwon-Sik Park, Sandra Cristea, Shrikant Deshpande, Vangipuram S. Rangan, Xi-Tao Wang, Huadong Sun, Heidi LeBlanc, Debbie Strachan, Miho Oyasu, Bing Chen, Chin Pan, Daniel Menezes, Paul Ponath
Purpose: The ganglioside fucosyl-GM1 (FucGM1) is a tumor-associated antigen expressed in a large percentage of human small cell lung cancer (SCLC) tumors, but absent in most normal adult tissues, making it a promising target in immuno-oncology. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd6c0ae145f942e06163a0de2e8b4d0
https://doi.org/10.1158/1078-0432.c.6529013
https://doi.org/10.1158/1078-0432.c.6529013
Autor:
Pina M. Cardarelli, Julien Sage, Kwon-Sik Park, Sandra Cristea, Shrikant Deshpande, Vangipuram S. Rangan, Xi-Tao Wang, Huadong Sun, Heidi LeBlanc, Debbie Strachan, Miho Oyasu, Bing Chen, Chin Pan, Daniel Menezes, Paul Ponath
4 suppl figures on tumor models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d253c03d289cadd2f8077bb43c5e3311
https://doi.org/10.1158/1078-0432.22475165.v1
https://doi.org/10.1158/1078-0432.22475165.v1
Autor:
Pina M. Cardarelli, Julien Sage, Kwon-Sik Park, Sandra Cristea, Shrikant Deshpande, Vangipuram S. Rangan, Xi-Tao Wang, Huadong Sun, Heidi LeBlanc, Debbie Strachan, Miho Oyasu, Bing Chen, Chin Pan, Daniel Menezes, Paul Ponath
4 suppl tables on FucGM1 expression in lung cancer, binding, and mouse PK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d62ed2c1d2fa823410527d226168d82
https://doi.org/10.1158/1078-0432.22475162
https://doi.org/10.1158/1078-0432.22475162
Autor:
Mélanie Desbois, Thierry Giffon, Poonam Yakkundi, Sivani Pandey, Rodnie Rosete, Daniel Machado, Marigold Manlusoc, Susan Calhoun, Tasnim Kothambawala, Jey Ananta, Kristina Koyama, Yuan Cao, Dean Ng, Tomas Miranda-Katz, Avneesh Saini, Abhinav Jain, Hongjun Yue, Yang Cai, Miho Oyasu, Liz Bogaert, Roel Funke, Genevive Hernandez, Denise Nagata, Maya Leabman, Eric Humke, Stephen Carroll, Beatrice Wang, Bruce Keyt, Angus Sinclair, Maya Kotturi
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Miho Oyasu, Angus M. Sinclair, Haben Ghermazien, Genevive Hernandez, Thomas Manley, Maya K. Leabman, Stephen F. Carroll, Bruce A. Keyt, Maya F. Kotturi
Publikováno v:
Cancer Research. 83:4120-4120
Imvotamab (IGM-2323) is an engineered high-affinity, high-avidity bispecific anti-CD20 IgM antibody T cell engager (TCE) that is currently being studied as monotherapy in a Phase 1/2 clinical trial for relapsed/refractory non-Hodgkin’s lymphoma (NH
Autor:
Beatrice T. Wang, Thomas J. Matthew, Poonam Yakkundi, Miho Oyasu, Mélanie Desbois, Susan E. Calhoun, Ling Wang, Tasnim Kothambawala, Devinder K. Ubhi, Marvin S. Peterson, Eric W. Humke, Maya F. Kotturi, Bruce A. Keyt, Angus M. Sinclair
Publikováno v:
Cancer Research. 83:6123-6123
Death receptor 5 (DR5) is a tumor necrosis factor receptor (TNF) superfamily member that requires multimerization to activate the extrinsic apoptotic pathway and is broadly expressed on solid and hematologic cancers. IGM-8444 is a multivalent IgM DR5
Autor:
Beatrice T. Wang, Melanie Desbois, Susan E. Calhoun, Thomas J. Matthew, Poonam Yakkundi, Ling Wang, Xingjie Chen, Tasnim Kothambawala, Miho Oyasu, Maya F. Kotturi, Genevive Hernandez, Xiaohan Liu, Marvin S. Peterson, Eric W. Humke, Bruce A. Keyt, Angus M. Sinclair
Publikováno v:
Cancer Research. 82:1068-1068
Apoptosis is induced through extrinsic and intrinsic signaling pathways. Extrinsic apoptosis can be activated through multimerization of death receptor 5 (DR5), a tumor necrosis factor (TNF) receptor family member highly expressed in many cancers. Ho
Autor:
Paul Ponath, Vangipuram S. Rangan, Huadong Sun, Pina M. Cardarelli, Xi-Tao Wang, Sandra Cristea, Debbie Strachan, Bing Chen, Chin Pan, Julien Sage, Daniel Menezes, Heidi N. Leblanc, Kwon-Sik Park, Shrikant Deshpande, Miho Oyasu
Publikováno v:
Clinical Cancer Research. 24:5178-5189
Purpose: The ganglioside fucosyl-GM1 (FucGM1) is a tumor-associated antigen expressed in a large percentage of human small cell lung cancer (SCLC) tumors, but absent in most normal adult tissues, making it a promising target in immuno-oncology. This